By Wafik S. El-Deiry
Read or Download Antisense Therapeutics PDF
Similar pharmacy books
The fourth quantity within the six-volume guide of Pharmaceutical production Formulations, this booklet covers semi-solid medicines. It comprises formulations of ointments, creams, gels, and suppositories, from publicly to be had yet generally dispersed info from FDA New Drug functions (NDA), patent purposes, and different resources of common and proprietary formulations.
Prescribing and drugs administration is without doubt one of the most typical interventions in healthiness care supply and sooner or later becomes a part of the function of many millions of nurses, pharmacists and different professions allied to medication (PAMs). self reliant and Supplementary Prescribing: an important advisor is the 1st booklet of its variety and explores a couple of key components for prescribers, together with the moral and criminal concerns surrounding prescribing, the psychology and sociology of prescribing, prescribing inside of a public health and wellbeing context, evidence-based prescribing, prescribing inside a group context, easy pharmacology, tracking abilities and drug calculations.
Whole in three volumes. Pharmaceutical know-how. 14 participants.
163 pages, fifty four figures
- Physicochemical calculations,, Edition: 1St Edition
- Drug Misuse and Community Pharmacy
- Pharmaceutical Compounding and Dispensing
- Medieval Pharmacotherapy - Continuity and Change (Studies in Ancient Medicine)
Extra resources for Antisense Therapeutics
2002) Intramural delivery of advanced antisense oligonucleotides with infiltrator cathetor inhibits c-myc expression and intimal hyperplasia in the porcine. J. Am. Coll. Cardiol. 39(10), 1686–1691. 21. 21 Sheppard, R. and Eisenberg, M. J. (2001) Intracoronary radiotherapy for restenosis. N. Engl. J. Med. 344(4), 295–297. 22. , et al. (2000) Local paclitaxel delivery for the prevention of restenosis: biological effects and efficacy in vivo. J. Am. Coll. Cardiol. 35(7), 1969–76. 23. 23 Sousa, J.
2 Chung, O. and Unger, T. (1999) Angiotensin II receptor blockade and end-organ protection. Am. J. Hypertens. 12, S150–S156. 3. , et al. (2002) Polymorphisms in the angiotensinogen and angiotensin II type 1 receptor gene are related to change in left ventricular mass during antihypertensive treatment: results from the Swedish Antisense Therapeutics for Hypertension 4. 4 5. 5 6. 6 7. 7 8. 8 9. 9 10. 10 11. 11 12. 13. 13 14. 14 15. 15 16. 16 17. 17 61 Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) trial.
1993) Chimeric renin-angiotensin system demonstrates sustained increase in blood pressure of transgenic mice carrying both human renin and human angiotensinogen genes. J. Biol. Chem. 268, 11,617–11,621. Davisson, R. , Stec, D. , et al. (1999) Novel mechanism of hypertension revealed by cell-specific targeting of human angiotensinogen in transgenic mice. Physiol. Genomics 1, 3–9. Merrill, D. , Thompson, M. , Carney, C. , et al. (1996) Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes.